 BOULDER, Colo.--BUSINESS WIRE--- BDSX patientsfirst--Biodesix, Inc. Nasdaq: BDSX, a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present in a fireside chat at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health Services Forum being held virtually November 18, 2021. Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health Services Forum Date: Thursday, November 18, 2021 